Table 4

Distribution of risk factors according to NT-proBNP levels at discharge and heart failure groups

NT-proBNP at discharge ≤3000 pg/mL
(n=580)
NT-proBNP at discharge >3000 pg/mL
(n=591)
HFpEFHFrEFP valueHFpEFHFrEFP value
Age ≥75 years, n (%)101 (58)92 (29)<0.00164 (67)199 (48)0.001
Ischaemic aetiology, n (%)97 (63)147 (51)0.02743 (54)174 (44)0.108
Peripheral oedema at admission, n (%)100 (63)162 (54)0.06066 (73)255 (65)0.218
SBP ≤115 mm Hg at admission, n (%)27 (16)84 (26)0.00724 (26)188 (45)<0.001
Atrial fibrillation at admission, n (%)85 (51)110 (37)0.00550 (57)162 (42)0.017
Anaemia at admission, n (%)77 (46)129 (41)0.29059 (63)241 (60)0.640
Hyponatraemia (<135 mmol/L) at admission, n (%)19 (14)34 (11)0.43518 (21)94 (23)0.778
Serum urea ≥15 mmol/L at admission, n (%)14 (11)31 (11)1.00032 (41)145 (39)0.899
Comorbidities ≤2, n (%)69 (63)196 (76)0.01128 (39)134 (40)0.895
Comorbidities >2, n (%)41 (37)62 (24)44 (61)199 (60)
  • HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; SBP, systolic blood pressure.